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ABSTRACT 
 The purpose of this study is to determine if early laparoscopic cholecystectomy in patients 
with uncomplicated gallstone disease and symptoms of dyspepsia will produce complete 
symptomatic resolution 1 year postoperatively and to identify appropriate timing of laparoscopic 
cholecystectomy to decrease cholecystectomy failure rate. Specific research objectives were to 
determine: 1) if laparoscopic cholecystectomy in patients with gallstones and symptoms of 
dyspepsia will achieve complete symptomatic relief; 2) the change in the preoperative score to 
the postoperative score and satisfaction after laparoscopic cholecystectomy for the two groups: 
patients with gallstones and symptoms of dyspepsia and the patients with gallstones and no 
dyspepsia; 3) the relationship between the duration of preoperative episodes and the probability 
of complete resolution of symptoms with laparoscopic cholecystectomy in patients with 
gallstones and symptoms of dyspepsia; 4)  the relationship between the frequency of preoperative 
episodes and the probability of complete resolution of symptoms with early laparoscopic 
cholecystectomy in patients with gallstones and symptoms of dyspepsia and 5)  the differences in 
pathologic findings between patients with gallstones and no symptoms of dyspepsia versus 
patients with symptoms of dyspepsia.  
 The methods included a retrospective chart review for patient identification, a follow up 
survey and microscopic pathological examination of gallbladder specimens. Nine hundred and 
forty two patients entered the study. Three hundred and fifty nine surveys were returned 
producing a response rate of 43%. Two hundred and sixty four patients (77.0%) had symptoms of 
dyspepsia (Group I) and 79 patients (23.0%) had no symptoms of dyspepsia (Group II).  
 Laparoscopic cholecystectomy for patients with gallstones and symptoms of dyspepsia 
does not achieve complete symptomatic relief 1 year after surgery. The frequency and duration of 
 iii
preoperative episodes have no relation to the outcome of surgery. The majority of patients in both 
Groups (I, II) were found to have morphological evidence of acute cholecystitis and only a small 
number had chronic cholecystitis. Group I had a greater reduction in the Buckley score than 
Group II after LC but had similar rates of satisfaction from surgery.  
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CHAPTER ONE 
OBJECTIVES AND HYPOTHESES 
1.1 Objectives  
1. To determine if laparoscopic cholecystectomy in patients with gallstones and 
symptoms of dyspepsia will achieve complete symptomatic relief. Complete symptomatic relief 
will be defined as the cessation of symptoms of dyspepsia after laparoscopic cholecystectomy.  
2. To compare the change in the preoperative score to the postoperative score and 
satisfaction after laparoscopic cholecystectomy for the two groups: patients with gallstones and 
symptoms of dyspepsia and the patients with gallstones and no symptoms of dyspepsia. 
3. To determine the relationship between the duration of preoperative episodes and the 
probability of complete resolution of symptoms following laparoscopic cholecystectomy in 
patients with gallstones and symptoms of dyspepsia. Duration measured by the total period of 
time between onset of symptoms and laparoscopic cholecystectomy.  
 4. To determine the relationship between the frequency of preoperative episodes and the 
probability of complete resolution of symptoms following laparoscopic cholecystectomy in 
patients with gallstones and symptoms of dyspepsia. Frequency measured by the number of 
episodes in the period of time prior to laparoscopic cholecystectomy.  
             5. To determine the differences in gallbladder pathology findings between patients with 
gallstones and no symptoms of dyspepsia versus patients with gallstones and symptoms of 
dyspepsia.  
1.2 Hypotheses 
The study was based on the following hypotheses: 
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1. Laparoscopic cholecystectomy for patients with gallstones and symptoms of dyspepsia 
will achieve complete symptomatic relief 1 year post laparoscopic cholecystectomy in 70% of 
patients. 
2. Patients with gallstones and no symptoms of dyspepsia would have a greater reduction 
in the Buckley score and greater satisfaction after laparoscopic cholecystectomy than those 
patients who have gallstones and symptoms of dyspepsia. 
3. Early laparoscopic cholecystectomy for patients with gallstones and symptoms of 
dyspepsia will achieve complete symptomatic relief 1 year post laparoscopic cholecystectomy in 
70% of patients. Early laparoscopic cholecystectomy is defined by surgical intervention at or 
before three months of symptoms. 
 4. Patients with gallstones and symptoms of dyspepsia will experience complete 
resolution of symptoms when laparoscopic cholecystectomy is performed prior to or at the third 
episode. 
 5a) Patients with no symptoms of dyspepsia and ultrasonagraphic evidence of gallstones 
would be found to have no morphological evidence of chronic cholecystitis. 
 5b) Patients with symptoms of dyspepsia and ultrasonagraphic evidence of gallstones 
would be found to have morphological evidence of chronic cholecystitis. 
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CHAPTER TWO 
CRITICAL REVIEW OF THE LITERATURE 
2.1 Definition of Biliary Colic 
Biliary colic is a syndrome typified by pain that ensues when an obstructing stone causes 
sudden distension of the gallbladder. “Colic” as defined in the dictionary as paroxysmal pain in 
the abdomen, is a misnomer, as biliary pain typically does not increase and decrease 
spasmodically. Severe right upper quadrant or epigastric pain begins suddenly and intensifies. 
This steady pain usually lasts between 15 minutes to six hours and then gradually disappears over 
30 to 90 minutes, leaving a vague ache and may be associated with nausea and vomiting. Its 
duration is seldom less than 15 minutes. The pain is often sufficiently severe for some to seek 
medical attention requiring the use of narcotics for relief. Episodes of pain occur irregularly 
(episodic), separated by pain-free periods lasting from days to years. The severity of pain also 
varies. This pain is unrelated to bowel movements and not associated with urination. (1). Biliary-
type pain can be precipitated following a large meal, the so-called “fatty food intolerance,” but is 
not specific for biliary tract disease. Biliary pain is mediated by splanchnic nerves and may 
radiate like angina to the back, right scapula or shoulder tip, or down the arm or into the neck. In 
rare circumstances, the pain may also be confined to the back. (2) 
2.2 Definition of Dyspepsia 
Dyspepsia as defined by the Rome II consensus report refers to pain or discomfort centered in 
the upper abdomen (3). It is common, with a prevalence of 40-60% in the general population. 
Dyspeptic symptoms are thought to originate in the upper gastrointestinal tract. These symptoms 
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may indicate gastroesophageal reflux disease (GERD), peptic ulceration, cholelithiasis, or upper 
gastrointestinal malignancy. Fifty percent of patients will have no underlying cause after upper 
gastrointestinal investigations (2). Functional (non-ulcer) dyspepsia was defined as dyspeptic 
symptoms present for at least 25% of the time for at least a month in the absence of definite 
structural disease (3). Presently, the most widely accepted mechanism explaining functional 
dyspepsia is visceral hypersensitivity, which may contribute to both enhanced motor and 
symptomatic responses to food ingestion (4). Individuals might refer to this symptom as 
“indigestion”.  Other symptoms that may also be reported in association with dyspepsia are: 
bloating, early satiety, nausea, and vomiting. Dyspepsia can be intermittent or continuous and can 
be related to meals. (2) 
2.2.1 Natural History of Dyspepsia 
A complete understanding of the natural history of functional dyspepsia remains elusive. 
Studies that evaluated the clinical course of functional dyspepsia have been inconsistent and 
suggest that a proportion of patients will improve or may go into remission. These studies lacked 
population-based studies and were partially confounded by including patients with reflux disease 
(5).  Sanft and Jones suggest patients with symptoms of dyspepsia will remain symptomatic over 
time (6). The exact prognosis is variable and continues to remain unpredictable.  
2.3 Laparoscopic Cholecystectomy and Patients with Dyspepsia 
Studies suggest that patients with gallstones who complain of dyspeptic symptoms without 
biliary colic are less likely to improve following cholecystectomy. However, approximately 70% 
of these patients will still benefit from surgery. This suggests that some of the dyspeptic 
symptoms may be caused by gallstones (7-9). Two studies have shown that biliary pain is 
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relieved in greater than 95% of patients after laparoscopic cholecystectomy after one year of 
follow-up (10,11). 
Borly et al (12) prospectively investigated whether preoperative factors could predict 
symptomatic outcome after cholecystectomy over a 2 year period. Before the operation a 
questionnaire, ultrasound and dynamic cholescintigraphy were completed. One year 
postoperatively, a new questionnaire was completed. The questionnaire consisted of 121 
questions on personal data, a visual analogue scale (VAS), and a Danish version of the McGill 
Pain Questionnaire (MPQ). The MPQ was used to look for preoperative descriptors that could 
predict the symptomatic outcome. A further 16 questions were on dyspeptic symptoms on a scale 
of yes (=1) or no (=0), that cumulatively made the dyspeptic score. The one year after the 
operation questionnaire consisted of the same VAS for pain and questions on dyspepsia as the 
preoperative questionnaire. One hundred patients were entered into the study and 80 patients had 
completed the questionnaire. Of the 80 patients, 71 were woman. Twenty one patients continued 
to experience abdominal pain after the operation and were characterized by the preoperative 
presence of a high dyspepsia score, irritating abdominal pain, and introverted personality.  
There were several limitations to this study. A power analysis was not included or described 
at all. Therefore sample size may have been insufficient. Secondly, the modified MPQ and the 
dyspeptic score have not been validated. The majority of the subjects were female. 
Lorusso et al (13) studied whether psychological factors can be associated with poor outcome 
after cholecystectomy in patients with uncomplicated gallstone disease and symptoms of 
dyspepsia by questionnaires. Fifty two (42 female, 10 male) patients were included in the study 
and were evaluated 2 weeks prior to surgery and 1 year post surgery. Criteria for defining 
dyspeptic patients were evaluated by two of the authors independently based on reported 
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symptoms by the patients.  The patients were assessed for psychological factors (90 item Hopkins 
Symptom Checklist) and by a Gastrointestinal Symptom Rating scale. Twenty one (40.4%) 
patients did not improve after surgery. These patients showed significantly higher psychological 
factors and dyspeptic symptoms than the improved group.  
The limitations to this study are sample size and lack of power analysis calculation. The 
evaluation of dyspeptic patients did not involve a validated scoring system.  
Middelfart et al (14) compared the occurrence of abdominal pain and dyspepsia 5-10 years 
after cholecystectomy in 2 groups of patients: acute cholecystitis (345) and symptomatic 
gallstones (296). Patients were included during the period of 1986 to 1990.  The questionnaire 
included questions on postoperative symptoms: duration of abdominal pain months to years 
(yes/no), severity of abdominal pain (VAS score), presence of 16 dyspeptic symptoms (yes/no), 
and outcome after surgery (cured/improved/same/ worse). Six hundred and forty one 
questionnaires sent and 519 returned (83% response rate). Complaints of pain after 
cholecystectomy were made by 194 (37%) patients. Complaints of abdominal pain and dyspepsia 
were found to be with similar frequencies in both the gallstone and acute cholecystitis group. 
One limitation of the study was evaluation only of patients who had undergone an open 
cholecystectomy (larger incision). The laparoscopic era began in 1991. This study also included 
patients with choledocholithiasis.  The strengths of this study are the number of patients enrolled 
and high response rate to the questionnaire. 
Luman et al (15) prospectively investigated the effect of laparoscopic cholecystectomy on 
patients’ symptoms before and after surgery. Ninety seven patients were evaluated using standard 
questionnaires. The standard questionnaire contained questions pertaining to pain characteristics 
(site, duration, frequency, quality, periodicity and alleviating and aggravating factors), dyspeptic 
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symptoms (nausea, vomiting, heartburn, food intolerance, early satiety) and colonic symptoms 
(bloating, constipation, and diarrhea). The questionnaire included a history of hysterectomies and 
psychiatric disturbances. The questionnaire was administered before surgery and 6-10 months 
after surgery via an outpatient review or an interview by telephone. Patients with complicated 
gallstone disease (history of jaundice, abnormal liver function tests, dilated common bile duct, 
and pancreatitis) were included in the study. The study group was 78 (80%) woman and 19 men 
(20%). Thirteen patients (13%) complained of pain similar to the pain prior to surgery and this 
group was the symptomatic group. Ten patients had symptoms less than 6 months and 3 patients 
had symptoms greater than 6 months. Abdominal bloating and previous use or current 
consumption of psychotropic drugs (antidepressants or anxiolytic) were significantly more 
common in this group. In this group, 77% had mild or no histological changes of cholecystitis. 
This study has several limitations. The size of the sample is small, the symptomatic group 
having only 13 patients. The questionnaire used, does not seem to have been validated. They also 
included patients with complicated gallstone disease (pancreatitis, common bile duct stones, and 
obstructive jaundice).  
Lublin et al. (16) investigated the persistence or resolution of symptoms associated with 
cholelithiasis after laparoscopic cholecystectomy. Between 1989 and 1995, a mailed validated 
survey of 1380 patients was conducted. The response rate was 44.3%. Pain was present in 75% of 
patients preoperatively, and non pain symptoms were present in 80%. Postoperatively, non pain 
symptoms (indigestion, fatty food intolerance, heartburn, nausea, vomiting, diarrhea, chills, fever, 
and jaundice) were significantly reduced. Preoperatively, longer duration of pain, frequent 
episodes of postprandial pain, age <40 and numerous sites of pain were all predictive of a higher 
 8
incidence of persistent pain after laparoscopic cholecystectomy. Postoperative diarrhea was 
experienced in 21% of patients. 
This study has several limitations. There were a significant number of patients (20%) who 
were asymptomatic that had their gallbladders removed (N=109), standard of practice in North 
America and would influence results. Also pediatric age group (12-18 yrs) patients were included 
as participants. The duration and frequency of pain experienced prior to surgery was not defined. 
All patients were operated in the time that laparoscopic cholecystectomy was in its 
developmental phase. All patients had intraoperative cholangiograms which may be a 
confounding variable. The authors claim to have used a validated survey tool, but make no 
reference to how that was defined or the actual survey itself.  Although they state the survey was 
created with the help of “survey professionals”, this in itself does not constitute validation. Also, 
participants received the survey approximately 4 years (mean) after surgery with the longest time 
between surgery and survey completion being 7 years. Memory recall would be a significant bias.  
2.4 Buckley’s Validated Dyspeptic Symptom Score 
Buckley et al. (17) produced a validated dyspeptic symptom score in 1997. For a symptom 
score to be valid, three criteria must be fulfilled: reproducibility, responsiveness, and validity. 
Fifty consecutive patients were recruited with a 3 month or greater history of dyspepsia. The 
control group was comprised of asymptomatic hospital employees who denied symptoms of 
indigestion or gastrointestinal disease and who were not taking any medications.  The dyspeptic 
group was asked to indicate from a list of 18 symptoms, the symptoms they experienced. The 
four most common symptoms were identified: epigastric pain, heartburn, belching/burping, and 
bloating. These were then assessed in relation to severity, frequency and duration of symptoms. 
Severity of symptoms was graded on a 5 point Likert scale. Frequency of symptoms was graded 
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on a 4 point scale and duration of symptoms was graded on a 3 point scale. The total symptom 
score was tabulated by the summation of individual severity, frequency, and duration scores.  
Study participants were questioned on initial presentation to clinic, one week later prior to 
diagnostic/therapeutic intervention and then after treatment. Reproducibility, responsiveness and 
validity were determined by comparing the scores of the dyspeptic group to the control group. 
Wilcoxon matched pairs signed rank test was used to analyze the reproducibility and 
responsiveness comparisons. The Kruskal-Wallis 1 way- ANOVA test was used to analyze the 
validity. Patients with dyspepsia had scores greater than 16. Healthy volunteers with no 
gastrointestinal symptoms had scores less than 6. This questionnaire is utilized for the assessment 
of patients with symptoms of dyspepsia. Our scoring criteria were derived from Buckley’s 
method and hence renders the criteria used as valid.  
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CHAPTER THREE 
THEORETICAL FRAMEWWORK 
3.1 Introduction 
 3.1.1 Gallbladder: Anatomy and Physiology 
 The gallbladder is described as a pear shaped sac approximately 7-10 cm in length. It has 
four anatomic areas: fundus, body, infundibulum, and neck. It is located in the fossa on the 
inferior surface of the liver.  The gallbladder via the cystic duct joins with the common hepatic 
duct to form the common bile duct that empties into the duodenum. The blood supply to the 
gallbladder is from the cystic artery, which originates from the right hepatic artery. The primary 
function of the gallbladder is to concentrate and store hepatic bile and deliver bile into the 
duodenum in response to a meal. (18)  
 3.1.2 Gallstone Disease 
 Gallstones are the most common cause of biliary tract disease in adults. Gallstones are 
composed of cholesterol and can be less often pigment stones. Cholesterol stones form as a result 
of cholesterol supersaturation, accelerated cholesterol crystal nucleation and impaired gallbladder 
motility (19). One to 2% of patients with asymptomatic gallstones will develop serious symptoms 
and complications annually (20). Less than 20% of individuals with gallstones will become 
symptomatic. Treatment is required for symptom relief and for complications of gallstones. 
Symptoms of gallstones can be nonspecific and include: biliary pain, abdominal pain, nausea and 
vomiting, bloating, flatulence, belching, heartburn, and food intolerance. Complications of 
gallstone disease include: acute cholecystitis, chronic cholecystitis, biliary colic, 
choledocholithiasis (common bile duct stones) with or without cholangitis, cholecystoenteric 
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fistula, gallstone pancreatitis and (very rarely) gallbladder carcinoma (19). Laparoscopic 
cholecystectomy is now the gold standard for symptomatic gallstones with an operative mortality 
rate less than 0.1% for elective cholecystectomy is (21).  
 3.1.2.1 Acute Cholecystitis: Pathophysiology, Clinical Manifestations and Diagnosis 
 The initiating event in acute cholecystitis is the obstruction of the cystic duct by a 
gallstone. This leads to gallbladder distention, inflammation and edema of the gallbladder wall. 
The gallbladder wall may become grossly thickened and reddish with subserosal hemorrhages. 
Pericholecystic fluid is commonly present. In some cases, the inflammatory process leads to 
progressive ischemia and necrosis of the gallbladder wall.  
 Clinically this manifests as an attack of biliary colic that does not subside and more 
severe. Often, the patient is febrile (temperature greater than 38 degrees Celsius) and may be 
associated with anorexia, nausea and vomiting. Physical exam may reveal focal tenderness, 
guarding in the right upper quadrant and a mass (gallbladder and adherent omentum). Murphy’s 
sign is characteristic of acute cholecystitis, which is described as an inspiratory arrest with deep 
palpation in the right subcostal area. 
 Laboratory investigations may reveal an elevated leukocyte count. Serum bilirubin and 
transaminases may be mildly elevated. Diagnosis is confirmed with ultrasonagraphy, which is the 
most useful radiologic test with a sensitivity and specificity of 95%. Ultrasonagraphy is useful for 
detecting stones (presence or absence), pericholecystic fluid, and gallbladder wall thickening. 
Focal tenderness over the gallbladder when compressed with the sonagraphic probe is described 
as the sonagraphic Murphy’s sign and may be suggestive of acute cholecystitits. (18) 
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 3.1.2.2 Chronic Cholecystitis 
 Chronic cholecystitis is characterized by recurrent attacks of pain. The pain develops as 
the stone obstructs the cystic duct and produces a progressive increase of tension in the 
gallbladder wall. The gallbladder may be contracted. (18) 
3.1.3 Operative Indications and Contraindications 
 Candidates for laparoscopic cholecystectomy are patients with symptomatic gallstones 
who can tolerate a general anesthetic and have no serious cardiopulmonary diseases or other co-
morbid conditions. Generally, patients with gallstones and vague symptoms should not undergo 
cholecystectomy (22) and those patients with one or more biliary colic attacks should be offered 
an operation. Those patients with gallstones and vague symptoms should undergo further 
investigations (23).  Contraindications for surgery are related to anaesthesiological considerations 
(severe co-morbidities), uncontrollable coagulopathy and pregnancy. (19) 
3.1.4 History of Cholecystectomy 
 Carl Langenbuch performed the first open cholecystectomy in 1882 in Berlin (24). This 
procedure was the gold standard for over a century (23). The first laparoscopic cholecystectomy 
was performed in 1985 in Germany (25). By 1993, the laparoscopic approach was declared the 
gold standard by the National Institutes of Health (NIH) consensus conference (23).  
Cholecystectomy can be completed in one of two procedures: laparoscopic or open. Laparoscopic 
cholecystectomy is the gold standard for the treatment of gallstone disease.  
3.1.4.1 Laparoscopic Cholecystectomy 
 The patient is placed supine and undergoes a general anesthetic with endotracheal 
intubation. The procedure requires four trocars placed in the peritoneal cavity. 
Pneumoperitoneum is established with carbon dioxide (CO2) insufflation through a closed 
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technique via a special hollow needle (Veress needle) or an open technique. A 10mm trocar is 
then inserted through a peri-umbilical incision. The laparoscope with an attached video camera is 
passed through this umbilical port. Three additional ports (epigastrium, mid-clavicular line, and 
flank) are placed under direct vision. The operation is performed and visualized through a video 
screen with magnification. 
 The most lateral port (flank) is used for an atraumatic grasper to grasp the gallbladder 
fundus and retract it cephalad. The mid clavicular port is used to grasp the infundibulum with an 
atraumatic grasper, and retract laterally and toward the right lower quadrant. The epigastrium port 
is used for the dissection by a laparoscopic dissector, hook or scissors. The hepatoduodenal 
ligament is dissected out to identify and skeletonize the cystic duct and artery. The duct and 
artery are then clipped and transected. The gallbladder is then dissected off the gallbladder fossa. 
The gallbladder is then removed through the umbilical incision. (18).  
3.1.4.2 Open Cholecystectomy 
 Open cholecystectomy is performed without the use of laparoscopy and CO2 
pneumoperitoneum. The patient undergoes a general anesthetic with endotracheal intubation. The 
patient is supine, prepped and draped in a sterile fashion. The surgery can be performed through 
either a large vertical midline or right subcostal (Kocher) incision. The dissection is the same as 
the laparoscopic procedure. 
 Compared with open cholecystectomy, laparoscopic cholecystectomy has significantly 
decreased the length of hospital stay (can be done as a day procedure), postoperative pain, and 
recovery time. However, there has been an increased incidence of major bile duct injuries since 
its inception. (26) 
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3.1.4.3 Complications from Cholecystectomy 
 Prior to surgery, the surgeon explains the potential complications that can occur from 
cholecystectomy to the patient as part of the informed consent. Complications from 
cholecystectomy can be divided into intraoperative and postoperative complications. 
Intraoperative complications can occur from the trocar insertions (to gain access to the abdominal 
cavity) and can subsequently cause a blood vessel or bowel injury. These can be very serious 
potential complications.  
 Inadvertent injury to surrounding structures during dissection can result in bile duct 
injuries occurring. These injuries have the highest associated morbidity. Postoperative 
complications include fever, bile/fluid collection, bile leak, and retained common bile duct 
stones.  
 Another intraoperative consideration is conversion to laparotomy (open cholecystectomy). 
This may be required based on the surgeon’s judgment. Most common reason for conversion to 
laparotomy (open through large midline or subcostal skin incision) is the inability to identify 
important anatomic structures.  
 Other potential causes for conversion are: distorted anatomy from previous surgeries, 
inflammation, anatomic anomalies/variations and intraoperative complications (vascular, bowel 
or bile duct injury). Conversion should be thought of as a prudent maneuver for achieving safe 
removal of the gallbladder and not a complication or failure. Risk of conversion for 
uncomplicated gallstone disease is less than 1% and for patients with acute cholecystitis or 
history of, may be as high as 20% (26).  
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3.1.5 Post Laparoscopic Cholecystectomy Pain 
After cholecystectomy for symptomatic gallstone disease, 20-30% of patients continue to 
have abdominal pain of unknown origin. This pain is described as persistent or intermittent 
symptoms similar to those symptoms experienced prior to the operation. Symptoms may be 
secondary to common bile duct stones, peptic ulcer disease or many other causes (27). 
Preoperative factors such as flatulence, dyspepsia, bloating, an introverted personality together 
and long duration of attacks of pain are risk factors for postoperative dissatisfaction (15). 
However, there is no literature to identify appropriate timing criteria for laparoscopic 
cholecystectomy in patients with dyspeptic symptoms and gallstones.  
3.1.6 Correlation between Preoperative Findings, Intraoperative Observations and 
Gallbladder Pathology   
The correlation between the preoperative findings, intraoperative observations and 
gallbladder pathology varies. For acute cholecystits, Bingener et al. found prospectively that the 
specificity for acute cholecystitis diagnosed on ultrasound examination was 77% compared to 
findings at operation and 71% relative to the histologic findings (28). This suggests that a small 
number of patients with a preoperative diagnosis of acute cholecystitis, will not have acute 
cholecystitis. Microscopic features of acute cholecystitis were edema, hemorrhage, necrosis; 
chronic cholecystitis as sclerosis, presence of haemosiderin pigment, scars and Rockitansky-
Aschoff sinuses (29, 30). There is a lack of literature demonstrating the correlation between 
gallbladder histology in patients with symptoms of dyspepsia.  
3.2 Study Purpose 
Up until now, it is clear in the literature that long duration of pain symptoms and symptoms 
of dyspepsia are risk factors for post laparoscopic cholecystectomy pain (12, 13, 15). However, 
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there is no literature showing that patients with of a short duration of symptoms of dyspepsia and 
uncomplicated gallstone disease are amenable to cure by laparoscopic cholecystectomy. This 
retrospective cohort study aims to investigate whether early laparoscopic cholecystectomy in 
patients with uncomplicated gallstone disease and symptoms of dyspepsia will produce complete 
symptomatic resolution 1 year postoperatively. Based on this, we hope to identify the appropriate 
timing of laparoscopic cholecystectomy for patients with uncomplicated gallstone disease and 
symptoms of dyspepsia.  
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CHAPTER FOUR 
METHODS 
4.1 Study Design 
This retrospective cohort includes a retrospective chart review of patients in the Saskatoon 
Health Region, a follow-up survey and microscopic pathological examination of gallbladder 
specimens (Figure 1). A pilot study was conducted to determine the feasibility of this project and 
to assist in determination of statistical power analysis (Appendix B). The estimated time period 
for this study was six months. 
4.2 Ethics 
The study protocol was approved by the Biomedical Research Ethics Board at the University 
of Saskatchewan (Appendix E). An ethics application was submitted to the ethics committee. In 
addition, a study proposal, consent form, a letter from the treating surgeon, and the questionnaire 
were submitted concurrently. All patients were informed about the nature and objectives of the 
study and informed consent was obtained. 
4.3 Patient Identification 
A computer search by procedure, “laparoscopic cholecystectomy”, was performed by the 
Health Records Manager at the Royal University Hospital Health Records with the Saskatoon 
Health Region database. An advantage was that the specified group of interest was accessible in a 
timely and efficient manner. The Health Records Manager had exclusive access to the database 
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and this was a limitation as this was accessible during business hours only. The address of each 
patient obtained from the chart review may not have been the current address which was another 
limitation. The computer search identified patients who had laparoscopic cholecystectomy (key 
words) in Saskatoon from the period of January 2004 to June 2005. The follow-up period was 
January 2005 to June 2006. This search included all three hospitals in the Saskatoon Health 
Region: Royal University, St. Paul’s, and City Hospital.  
 Figure 1: Study Design   
 
 
 
 
 
4.3.1 Inclusion Criteria 
All patients greater than 18 years of age, who had laparoscopic cholecystectomy in the 
Saskatoon Health Region, uncomplicated gallstone disease and patients with acute cholecystitis 
were included. Patients with uncomplicated gallstone disease were defined as biliary colic and 
cholelithiasis and those patients with acute cholecystitis were included. For this study, acute 
cholecystitis was defined as uncomplicated gallstone disease as there is a discrepancy in the 
preoperative clinical findings with intraoperative findings and microscopic examination of 
gallbladder specimens. 
4.3.2 Exclusion Criteria 
The exclusion criteria involved patients with complicated gallstone disease. Any one of the 
following were considered as complicated gallstone disease and were excluded: previous 
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common bile duct stones (choledocholithiasis), obstructive jaundice, cholangitis, gallstone 
pancreatitis, cholecystoenteric fistula, gallbladder neoplasm, previous biliary/pancreatic surgery, 
open cholecystectomy and previous gastric surgery.  
4.4 Data Extraction 
Medical charts from patients that had laparoscopic cholecystectomy in the Saskatoon Health 
Region were obtained from each hospital by computer search by procedure (laparoscopic 
cholecystectomy) and admitting diagnoses. Primary exclusion was done by excluding patients 
through the admitting diagnoses identified by the search (Figure 1). A survey of the charts was 
done by the author to apply the inclusion criteria and to complete the secondary exclusion. This 
group of patients was eligible for data abstraction. Then a questionnaire was mailed out to this 
patient group, based on the address derived from the patient’s medical chart, from the University 
of Saskatchewan Department of Surgery with a description of the study, consent form and an 
accompanying letter supporting the study from the treating surgeon. The mailings and 
questionnaire was administered by an outside commercial business that ensured maintenance of 
confidentiality as a term of the agreement.  
The chart review was used to obtain the data pertaining to the following variables: age, 
gender, preoperative ultrasound abdomen results, surgeon’s preoperative and postoperative 
(intraoperative) diagnosis, type of surgery (urgent/emergent or elective) and surgical accession 
number. 
4.5 The Survey Questionnaire 
The survey (Appendix C) that was administered contained the validated dyspeptic score by 
Buckley et al. (17). This survey contained two aspects: before and after treatment. The 
questionnaire contained the following preoperative variables: duration of symptoms, frequency of 
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symptoms, gastroscopy (results and timing), Buckley’s dyspeptic score, hospitalized with fever 
and gallbladder attack, medical history, and medication use (over the counter and prescribed). 
The postoperative variables were: time since laparoscopic cholecystectomy, satisfaction with 
surgery, visits to physicians, procedures (gastroscopy, ERCP), investigations (U/S or CT scan 
abdomen), medication use, diarrhea, and Buckley’s dyspeptic symptom score items. The 
questionnaire also included questions that would determine if a patient had acute cholecystitis, or 
endoscopy for peptic ulcer disease. Patient satisfaction with the procedure was measured on a 
three point scale: not satisfied, satisfied or very satisfied. Complete cessation of symptoms was 
tabulated as a postoperative Buckley score of 6 or less. 
 4.5.1 Timing of Mailing 
The first surveys were sent out and were followed by a second mailing approximately three 
weeks later. This was a reminder for subjects and to encourage participation to increase patient 
enrollment into the study. The dates of the study were extended to include those patients who had 
laparoscopic cholecystectomy during the period of August 2003 to December 2003 and June 
2005 to October 2005 to increase enrollment. For those surveys that were returned to senders 
(sent back to author unopened), the phone book was used to identify a current address and then 
the survey was resent. 
4.6 The Validated Dyspepsia Score 
The information from the questionnaire provided a means to calculate the validated dyspepsia 
score. A five point Likert scale was used. The total Buckley symptom score is calculated by the 
sum of individual severity, frequency and duration scores for each of the following symptoms: 
epigastric pain, heartburn, belching/burping and bloating. Each item was scored on a scale: 
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severity 1-5, frequency 1-4, and duration 1-3. The preoperative and postoperative Buckley scores 
was calculated by simple addition of all item scores.  
4.6.1 Identification of Patients with Dyspepsia 
Using the validated dyspeptic score as defined by Buckley et al (17), a score of 16 or greater 
defined those patients with symptoms of dyspepsia. A score of 6 or less defined normal patients 
that were asymptomatic with respect to dyspepsia. As such, the study analysis used these two cut 
points.  
4.7 Pathological Examination 
Specimens were located based on surgical accession number derived from the medical chart 
review. An employee was hired from the pathology department to locate the specimens and 
provided them to the pathologist. These specimens were located at all three hospitals in the 
Saskatoon Health Region. The individual specimens were on individual slides with the surgical 
accession number as the only identifying information.  
Microscopic pathological examination of all gallbladder specimens were done to identify 
gallbladder morphology by a single pathologist who was blinded to the early (original) 
pathological report and to the surgeon’s diagnosis. In addition, the pathologist did not know the 
ultrasound and intraoperative findings.  This was correlated with the preoperative ultrasound 
results later by the author. 
4.7.1 Classification of Gallbladder Pathology 
The classification of gallbladder pathology was standardized according to the following: 
acute cholecystitis, chronic cholecystitis and normal gallbladder. Acute cholecystitis included 
acute gangrenous cholecystitis and subacute cholecystitis. Chronic cholecystitis included 
cholesterolosis. This classification was used by the pathologist to review the gallbladder 
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specimens accordingly. This classification is most commonly used amongst most surgical 
textbooks and the literature. 
4.8 Data Management 
Data was recorded on paper (Appendix F) then entered into a computerized database 
(Microsoft Excel). Statistical analysis included a power analysis to determine sample size. To 
estimate sample size with an alpha error of 0.05 and a power of 90% (2 sided test), we would 
require a minimum of 59 subjects per group to detect a difference of 15% with respect to 
postoperative satisfaction in 2 groups. We estimate satisfaction from surgery for Group I to be 
75% and 90% for Group II one year post laparoscopic cholecystectomy.  
Paired Student’s T-test was used for intragroup analyses. Independent Samples T-test was 
used to compare means for two groups. Pearson’s Chi-square was used to test the significance of 
the relative frequencies of observed events that were measured as categorical outcomes. The 
McNemar test, a nonparametric test uses the chi-square distribution, was used to test changes in 
response for “before and after” designs. Wilcoxon Rank Sum test, a nonparametric analog of the 
paired T-test, was used to compare changes over time for outcomes measured on Likert (ordinal) 
scales. It is based on the order in which the observations from two samples fall. Sample size 
calculations were based on the literature and the pilot study (Appendix B). A p-value <0.05 was 
used to indicate a significant difference.  
 4.9 Response Rate Calculation 
 A variety of options are available for response rate calculations and these are summarized 
by the American Association of Public Research (AAOPI) (31). For the purpose of this study, the 
response rate calculation #5 (RR#5) as defined by the AAOPI (31) was used. It estimates that 
there are no eligible cases among those cases of unknown eligibility. As well, AAOPI define the 
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“not eligible” criteria for mail surveys to include those that are returned to senders.   Therefore 
the calculation is as follows: 
 
                 Completed surveys 
 RR# 5 =  ________________________________________ (4.1) 
      Completed surveys + Non Responders + Refusals 
This seems reasonable and was a conservative approach to a response calculation. 
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CHAPTER FIVE 
 
RESULTS 
  
5.1. Surgeon Participation and Procedures 
 Eighteen out of 19 (95%) surgeons who perform laparoscopic cholecystectomy consented 
to participation in the study. From August 2003 to October 2005, there were 1208 laparoscopic 
cholecystectomies performed in the Saskatoon Health Region. One thousand one hundred and 
fifty-five medical charts were reviewed. 
5.2 Description of Patients who were Excluded 
 In total, 266 (22.0%) patients were excluded based on primary and secondary exclusion 
criteria (Figure 2). The patients that were excluded had: 107 (40.2%) common bile duct stones 
(choledocholithiasis), 16 (6.0%) obstructive jaundice, 22 (8.3%) cholangitis, 96 (36.1%) 
gallstone pancreatitis, 4 (1.5%) gallbladder neoplasm, 1 (0.4%) previous biliary/pancreatic 
surgery, 2 (0.8%) open cholecystectomy, 10 (3.8%) previous gastric surgery, and 8 (3.0%)  other. 
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Figure 2: Excluded Patients Based on Diagnosis 
 
5.3 Survey Distribution and Response Rates 
 The study period was 5 months. After the primary exclusion criteria were applied, 1155 
medical charts were reviewed and then the secondary exclusion criteria were applied. A total of 
942 patients were eligible combining the first, second, and third mailings (Figure 3). Survey 
questionnaires were mailed to these patients. The number of surveys sent in the first round was 
680. After 4 weeks, surveys were sent to those who did not respond. A total of 249 patients 
responded to the survey and were entered in the study after two mailings.  
 We expanded the dates to obtain more patients because we were short of our required 
sample size. A second computer search for laparoscopic cholecystectomy was done by health 
records for the following time periods: September 2003 to December 2003 and July 2005 to 
September 2005. Primary exclusion was done based on diagnoses and then a second chart review 
with secondary exclusion was completed by the author. A third mailing was sent after 1 month. 
Two hundred and sixty two surveys were mailed. After 4 weeks, surveys were sent again to those 
who did not respond (fourth mailing). For patients who were “return to senders”, current 
addresses were acquired from directories and were included in the fourth mailing. This yielded 9 
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additional study participants and a total of 94 additional patients were included in the study for a 
total of 343.  A total of 15 patients refused to participate in the study. The total number of “return 
to senders” and non responders were 141 and 443 respectively. The “return to senders” are those 
that were mailed back by the postal service as undeliverable, therefore considered ineligible (out 
of scope).  The total response rate was 42.8% with non responders included in the denominator.  
 
Figure 3: Study Design Results 
 
 
 
 
 
 
 
 
 
 
 
 
5.4 Nonresponder and Return to Senders compared to Study Participants  
 We compared the nonresponder patients’ and the return to sender patients’ data to the 
study participants in Table 1. From the table, the two groups are for the most part very similar 
except for age (p=0.008). 
Saskatoon Health Records Search:
Laparoscopic Cholecystectomy
1208
Primary Exclusion
53
Charts Reviewed
1155
Secondary Exclusion
213
Surveys Mailed
942
Surveys Returned
358
Non Responders 443
Return to Senders 141
Participants
343
Refusal to Participate
15
Dyspepsia
264
Non Dyspepsia
79
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 Table 1: Demographic and Clinical Data Comparison of Non Responders/Return to 
Senders (NR/RS) vs. Study Participants (SP) 
 
Item    NR/RS  SP   p-value* 
    N=584   N=343  
Age    46.1 ±16.8  50.8 ±15.2  0.008 
Gender 
 Males   145 (24.8%)  93 (27.1%)  0.434 
 Females  439 (75.2%)  250 (72.9%)   
Results Preop U/S abdomen       0.731  
 Gallstones  484 (82.9%)  267 (77.6%)   
 Acute chole  88 (15.1%)  59 (17.2%)   
 No stones  4 (0.7%)  9 (2.6%)   
Type of Surgery        0.533 
 Emergent  126 (21.6%)  73 (21.2%)   
 Elective  221 (37.8%)  130 (37.8%)   
 Urgent   237 (40.6%)  140 (40.7%)   
Preoperative Diagnosis       0.458 
 Gallstones  133 (22.8%)  75 (21.8%)   
 Biliary colic  294 (50.3%)  162 (47.1%)   
 Acute chole  108 (18.5%)  69 (20.1%)   
Postoperative Diagnosis       0.635 
 Gallstones  127 (21.7%)  73 (21.2%)   
 Biliary colic  290 (49.7%)  161 (46.8%)    
 Acute chole  111 (19.0%)  71 (20.6%)   
*Pearson Chi square test except for Age (Independent Student’s t-test) 
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5.5 Characteristics of Study Groups 
 Characteristics of all study participants are displayed in Table 2. The mean age of the 
study participants was 50.8 years (range: 18-90). The majority of the study sample consisted of 
females (72.7%). Most patients (97.4%) had gallstones on ultrasound. One hundred and forty one 
(41.1%) patients experienced diarrhea after surgery.  
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Table 2: Demographic and Clinical Data of all Patients 
Characteristic    Patients   
      N=343   
Age      50.8 ±15.2    
Gender 
 Male     93 (27.1%) 
 Female     250 (72.7%) 
Duration of symptoms (months)   32.4 ±66.5                  
Preop Gastroscopy    65 (18.9%)     
Results for Preop Gastroscopy: 
 Abnormal    35 (10.2%)   
 Normal     29 (8.4%)   
Hospitalized with fever and GB episode 36 (13.6%)   
Medical history  
 DM     25 (7.3%)                            
 CAD     26 (7.6%)   
 Stroke     4 (1.2%)   
Results for Preop U/S abdomen: 
 Gallstones    267 (77.6%)   
 Acute chole    59 (17.2%)   
 No stones    9 (2.6%) 
Type of surgery:  
 Emergent    73 (21.2%)   
 Urgent     130 (37.8%)    
 Elective    140 (40.7%)   
Preop Diagnosis 
 Gallstones    75 (21.8%)   
 Biliary colic    162 (47.1%)   
 Acute chole    69 (20.1%)   
Postop Diagnosis     
 Gallstones    73 (21.2%)   
 Biliary colic    161 (46.8%)   
 Acute chole    71 (20.6%)   
Timing of surgery from onset of symptoms: 
 12 months    78 (22.7%)   
 18 months    112 (32.6%)   
 24 months    142 (41.3%)   
 36 months    9 (2.6%)   
Satisfaction  
 Not satisfied    18 (5.2%)   
 Satisfied    99 (28.8%)   
 Very Satisfied    224 (65.1%)   
Diarrhea (Postop)    141 (41.1%)   
Pathology (microscopic) 
 Acute chole    194 (56.4%)   
 Chronic chole    117 (34.0%)   
 Normal     31 (9.0%) 
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 The two groups: Patients with gallstones and symptoms of dyspepsia (Group I) and those 
patients with gallstones and without symptoms of dyspepsia (Group II) are compared in Table 3. 
Two hundred and sixty four patients (77.0%) were in Group I and 79 patients (23.0%) were in 
Group II. There was no statistically significant difference between the two groups in terms of age, 
gender, duration of symptoms, preoperative gastroscopy, past medical history, urgency and 
timing of surgery. After surgery, there was a statistical difference in patients having postoperative 
diarrhea in Group I (45.5%) compared to Group II (26.6%) (p<0.001). 
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Table 3: Demographics and Clinical Data of Group I patients (Dyspeptic) and Group II 
(Non Dyspeptic) 
 
Characteristic    Group I  Group II     p-value* 
      N=264   N=79 
Age      51.1 ±15.6  49.8 ± 13.8 0.25  
Gender  
 Male     67 (25.4%)  26 (32.9%) 0.43 
 Females    197 (74.6%)  53 (67.1%)  
Duration of symptoms (months)   36.4 ±71.5  19.2 ±43.8 0.10 
Preoperative Gastroscopy   56 (21.2%)  9 (11.4%) 0.542  
 Abnormal    29 (11.0%)  6 (7.6%)  
 Normal     26 (9.8%)  3 (3.8%)  
Hospitalized with fever and GB episode  36 (13.6%)  12 (15.2%) <0.001 
Medical history          0.283 
 Diabetes Mellitus   18 (6.8%)  7 (8.9%)  
 Coronary Artery Disease  18 (6.8%)  8 (10.1%)  
 Stroke     4 (1.5%)  0   
Preoperative U/S         0.108 
 Gallstones    201 (76.1%)  66 (83.5%)  
 Acute cholecystitis   49 (18.6%)  10 (12.7%)  
Surgery          0.420 
 Emergent    55 (20.8%)  18 (22.8%)  
 Urgent     104 (39.4%)  26 (32.9%)  
 Elective    105 (39.8%)  35 (44.3%)  
Preoperative Diagnosis         0.783 
 Gallstones    55 (20.8%)  18 (22.8%)  
 Biliary colic    123 (46.2%)  39 (49.4%)  
 Acute cholecystitis   57 (21.6%)  12 (15.2%)  
Postoperative Diagnosis         0.581 
 Gallstones    55 (20.8%)  18 (22.8%)  
 Biliary colic    122 (46.2%)  39 (49.4%)  
 Acute cholecystitis   59 (22.3%)  12 (15.2%)  
Timing of surgery         0.571 
 12 months    62 (23.5%)  16 (20.3%)  
 18 months    84 (31.8%)  29 (36.7%)  
 24 months    109 (41.3%)  33 (41.8%)  
 36 months    8 (3.0%)  1 (1.3%)  
Satisfaction          0.738  
 Not satisfied    15 (5.7%)  3 (3.8%)  
 Satisfied    85 (32.3%)  14 (17.7%)  
 Very Satisfied    162 (61.4%)  62 (78.5%)  
Diarrhea Postoperative    120 (45.5%)  21 (26.6%) <0.001 
Pathology          0.108 
 Acute cholecystitis   143 (54.2%)  51 (64.6%)  
 Chronic cholecystitis   99 (37.5%)  18 (22.8%)  
 Normal     21 (8.0%)  10 (12.7%) 
*Chi square test except for Age, Duration of symptoms (independent student’s t-test); Diarrhea and 
Hospitalization with fever and GB episode (McNemar Chi Square test) 
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5.6 Comparison of Total Preoperative to Total Postoperative Buckley Scores 
 Mean cumulative scores of each group are shown in Table 4. For both groups, there was a 
substantial change in scores between the preoperative and postoperative Buckley scores which 
was statistically significant (p-value 0.001). Figures 4 and 5 show the distribution of Buckley 
scores before and after surgery for Group I and Group II. These figures reinforce visually the 
substantial change in scores between the preoperative and postoperative Buckley scores for both 
groups. Figure 5b, shows that 44 patients (55.7%) in Group II had postoperative scores less than 
6.  
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Table 4a: Comparison of Buckley Total Scores: Preoperative vs. Postoperative (Group I) -
Median, (Mode) 
   Group I   p-value*              
Item  Preop       Postop       
Scores  24 (20)  12 (4)    0.001    
* Paired Student’s T-test 
 
Figures 4: Total Preoperative and Postoperative Buckley Scores for Group I  
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Table 4b: Comparison of Buckley Total Scores: Preoperative vs Postoperative (Group II) - 
Median, (Mode) 
   Group II  p-value*         
Item  Preop       Postop   
Scores  12 (12)  4 (4)      0.001 
* Paired Student’s T-test 
 
Figure 5: Total Preoperative and Postoperative Buckley Scores for Group II 
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5.7 Analysis of Group I (Dyspeptic) Buckley scores and Satisfaction after Surgery 
Table 5 shows the distribution of patients in Group I classified based on postoperative Buckley 
scores less than or equal to 6 and larger than 6. The majority of patients (81.4%) in Group I had 
scores larger than 6 after surgery. 
Table 5: Buckley Postoperative Scores in Group I (Dyspeptic) 
 Buckley Postop Scores in Group I (Dyspeptic) 
 
  Frequency Percent Valid Percent 
Cumulative 
Percent 
<=6 49 18.6 18.6 18.6
>6 215 81.4 81.4 100.0
Valid 
Total 264 100.0 100.0  
 
Table 6a: Buckley Postoperative Scores in Group I (Dyspeptic) 
 Buckley Postop Scores in Group I (Dyspeptic) 
 
  Frequency Percent Valid Percent 
Cumulative 
Percent 
0-6 49 18.6 18.6 18.6
7-15 119 45.1 45.1 63.6
16-48 96 36.4 36.4 100.0
Valid 
Total 264 100.0 100.0  
 
Table 6b: Satisfaction After Surgery in Group I (Dyspeptic) 
 
 Satisfaction in Group I (Dyspeptic) 
 
  Frequency Percent Valid Percent 
Cumulative 
Percent 
no answer 2 .8 .8 .8 
not satisfied 15 5.7 5.7 6.4 
Satisfied/very satisfied 247 93.6 93.6 100.0 
Valid 
Total 264 100.0 100.0   
 
 
 
 
 
 
Satisfaction 
Score 
Score 
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 The majority of patients in Group I did not achieve complete symptomatic relief 1 year 
after surgery as defined by a postoperative Buckley score of less than 6 (Figure 4, Tables 5,6a). 
Only 18.6% of Group I patients achieved a Buckley score between 0 and 6 after laparoscopic 
cholecystectomy. Thirty six percent of Group I patients were still dyspeptic (scores>16) 1 year 
after laparoscopic cholecystectomy. However, the majority, 179 patients (67.8%) had Buckley 
scores of 16 or less after surgery (Table 6a). Based on satisfaction 1 year after surgery (Table 6b), 
93.6% of Group I patients were either satisfied or very satisfied. 
5.8 Comparison of Preoperative to Postoperative Buckley Scores for each Symptom 
 Tables 7 (Figures 6-17) and 8 (Figures 18-29) show the before and after surgery Buckley 
scores for each symptom for Groups I and II. Group I patients were found to have a significant 
improvement in all the symptoms: epigastric pain, heartburn, belching/burping and bloating 
(p<0.001). For the patients in Group II, epigastric pain in terms of severity, frequency and 
duration decreased after surgery and this was statistically  significant (p<0.001). The other 
symptoms: heartburn, belching/burping and bloating were not significantly different before and 
after surgery. 
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Table 7: Comparison of Buckley scores for Group I: Dyspeptic (median values)   
        
Item    Preop  Postop  *p-value see Figure 
 
Epigastric pain 
 Severity  4   1   <0.001  6 
 Frequency  1    0   <0.001  7 
 Duration  3    0   <0.001  8 
  
Heartburn 
 Severity  3   2  <0.001  9  
 Frequency  1    1    <0.001  10  
 Duration  2    1    <0.001  11 
 
Belching/Burping 
 Severity  2    2    <0.001  12 
 Frequency  1    1   <0.001  13 
 Duration  1    1  <0.001  14 
 
Bloating 
 Severity  3    1  <0.001  15 
 Frequency  1    0   <0.001  16 
 Duration  2   0   <0.001  17 
*Wilcoxon Rank Sum test
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Figure 6: Comparison of Buckley Preoperative and Postoperative scores for Epigastric Pain 
Severity - Median Values: Group I (Dyspeptic)          
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Figure 7: Comparison of Buckley Preoperative and Postoperative scores for Epigastric Pain 
Frequency - Median Values: Group I (Dyspeptic)          
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Figure 8: Comparison of Buckley Preoperative and Postoperative scores for Epigastric Pain 
Duration - Median Values: Group I (Dyspeptic)          
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Figure 9: Comparison of Buckley Preoperative and Postoperative scores for Heartburn 
Severity - Median Values: Group I (Dyspeptic)          
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Figure 10: Comparison of Buckley Preoperative and Postoperative scores for Heartburn 
Frequency - Median Values: Group I (Dyspeptic)          
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Figure 11: Comparison of Buckley Preoperative and Postoperative scores for Heartburn 
Duration - Median Values: Group I (Dyspeptic)          
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Figure 12: Comparison of Buckley Preoperative and Postoperative scores for 
Belching/Burping Severity - Median Values: Group I (Dyspeptic)           
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Figure 13: Comparison of Buckley Preoperative and Postoperative scores for 
Belching/Burping Frequency- Median Values: Group I (Dyspeptic)         
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Figure 14: Comparison of Buckley Preoperative and Postoperative scores for 
Belching/Burping Duration - Median Values: Group I (Dyspeptic)          
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Figure 15: Comparison of Buckley Preoperative and Postoperative scores for Bloating 
Severity - Median Values: Group I (Dyspeptic)          
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Figure 16: Comparison of Buckley Preoperative and Postoperative scores for Bloating - 
Median Values: Group I (Dyspeptic)          
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Figure 17: Comparison of Buckley Preoperative and Postoperative scores for Bloating 
Duration - Median Values: Group I (Dyspeptic)          
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Table 8: Comparison of Buckley scores for Group II: Non Dyspeptic (median values)  
     
Item    Preop  Postop  *p-value see Figure  
 
Epigastric Pain 
 Severity  3   1   0.001  18  
 Frequency  1   0  0.001  19 
 Duration  2     0   0.001  20 
 
Heartburn  
 Severity  1  1  0.71  21 
 Frequency  0  0  0.36  22  
 Duration  0  0  0.30  23 
 
Belching/Burping 
 Severity  1  1  0.35  24 
 Frequency  0   0  0.46  25 
 Duration  0    0  0.11  26 
 
Bloating 
 Severity  1   1  0.10  27 
 Frequency  0   0  0.33  28 
 Duration  0   0  0.18  29 
*Wilcoxon Rank Sum test 
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Figure 18: Comparison of Buckley Preoperative and Postoperative scores for Epigastric 
Pain Severity- Median Values: Group II (Non Dyspeptic)          
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Figure 19: Comparison of Buckley Preoperative and Postoperative scores for Epigastric 
Pain Frequency- Median Values: Group II (Non Dyspeptic)                    
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Figure 20: Comparison of Buckley Preoperative and Postoperative scores for Epigastric 
Pain Duration- Median Values: Group II (Non Dyspeptic)             
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Figure 21: Comparison of Buckley Preoperative and Postoperative scores for Heartburn 
Severity- Median Values: Group II (Non Dyspeptic)                    
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Figure 22: Comparison of Buckley Preoperative and Postoperative scores for Heartburn 
Frequency- Median Values: Group II (Non Dyspeptic)                    
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Figure 23: Comparison of Buckley Preoperative and Postoperative scores for Heartburn 
Duration - Median Values: Group II (Non  Dyspeptic)                     
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Figure 24: Comparison of Buckley Preoperative and Postoperative scores for 
Belching/Burping Severity - Median Values: Group II (Non  Dyspeptic)                     
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Figure 25: Comparison of Buckley Preoperative and Postoperative scores for 
Belching/Burping Frequency - Median Values: Group II (Non  Dyspeptic)                     
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Figure 26: Comparison of Buckley Preoperative and Postoperative scores for 
Belching/Burping Duration - Median Values: Group II (Non  Dyspeptic)          
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Figure 27: Comparison of Buckley Preoperative and Postoperative scores for  Bloating 
Severity - Median Values: Group II (Non  Dyspeptic)                    
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Figure 28: Comparison of Buckley Preoperative and Postoperative scores for Bloating 
Frequency- Median Values: Group II (Non  Dyspeptic)                    
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Figure 29: Comparison of Buckley Preoperative and Postoperative scores for Bloating 
Duration - Median Values: Group II (Non  Dyspeptic)                     
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5.9 Comparison of Reduction in Buckley scores 
 The Gain score analysis between the two groups is shown in Table 9. Epigastric pain 
(frequency) and belching/burping (severity and duration) were shown not be statistically 
significant. However, the remainder of the scores were statistically significant, indicating that 
Group I patients had statistically significant larger reduction in Buckley scores from preoperative 
to postoperative than Group II patients (p-value<0.03).   Table 10 illustrates the change in the 
sum of each component of the Buckley score (severity+frequency+duration) from preoperative to 
postoperative. The change for all items was shown to be statistically significant in favor of Group 
I. However, the clinical magnitude is only large for the epigastric pain component.  
 Total Buckley Scores for each component (severity+frequency+duration) are shown 
relative to preoperative and postoperative for Groups I and II in Tables 11 and 12. For Group I, 
the total Buckley scores are statistically significant from preoperative to postoperative for all 
components. The clinical magnitude is only seen to be large for the epigastric component. There 
is only one component that is statistically significant for Group II and that is for the epigastric 
component (p<0.001) and the clinical magnitude is also large.   
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Table 9: Comparison of Difference in Buckley Scores by Group: Postoperative- 
Preoperative (median values) for each item.  
  
Item          Group I       Group II   *p-values 
           
 Epigastric pain        
 Severity  3  2   0.002 
 Frequency  1  0   0.093 
 Duration  2  1   0.03 
  Heartburn          
 Severity  1  0   <0.001 
 Frequency  0  0   <0.001 
 Duration  1  0   <0.001 
  Belching/Burping 
 Severity  0  0   0.14 
 Frequency  0  0   0.001 
 Duration  0  0   0.89 
  Bloating  
 Severity  0  0   <0.001 
 Frequency  0  0   0.001 
 Duration  0  0   <0.001 
*Wilcoxon Rank Sum test 
 
Table 10: Difference in Preoperative and Postoperative total Buckley Score 
(severity+frequency+duration) for each item. Median, (Mode) 
  
Item     Group I   Group II *p-value 
Epigastric Pain  6 (8)    3 (0)  0.017 
Heartburn   2 (0)    0 (0)  <0.001 
Belching/Bloating  1 (0)    0 (0)  0.035 
Burping   0 (0)    0 (0)  0.01 
*Wilcoxon Rank Sum test 
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Table 11: Total Buckley Score for each item (severity+frequency+duration) for Group I  
 
Item       Group I   p-value 
    Preop    Postop 
Epigastric Pain  9 (9)    1 (1)  <0.001 
Heartburn   7 (8)    4 (1)  <0.001 
Belching/Bloating  5 (1)    4 (1)  <0.001 
Burping   6 (1)    1 (1)  <0.001 
*Wilcoxon Rank Sum test 
 
Table 12: Total Buckley Score for each item (severity+frequency+duration) for Group II  
 
Item       Group II   *p-value 
    Preop    Postop 
Epigastric Pain  7 (9)    1 (1)  <0.001 
Heartburn   1 (1)    1 (1)  0.362 
Belching/Bloating  1 (1)    1 (1)  0.684 
Burping   1 (1)    1 (1)  0.171 
*Wilcoxon Rank Sum test 
 
5.10 Duration of Symptoms and Postoperative Buckley Score and Satisfaction after Surgery  
 The majority of Group I patients (76.1%) had symptoms of dyspepsia longer than 3 
months prior to LC (Figure 30, Table 13). Table 14 shows that the majority of Group I patients 
had symptoms longer than 3 months and had postoperative Buckley scores greater than 6. The 
majority of Group I patients (66.0%) had postoperative Buckley scores larger than 6 and had 
preoperative symptoms longer than 3 months. Only 34.9% of Group I patients with symptoms 
less than and equal to 3 months achieved a Buckley score less than 6 one year after LC. Of all 
Group I patients (N=63) having symptoms for less than or equal to 3 months, 65.1% had Buckley 
scores greater than 6 at one year after surgery. Table 15, shows that of 199 Group I patients who 
had symptoms greater than 3 months, 94.0% were either satisfied or very satisfied after surgery. 
Table 15 shows a statistically significant difference between the two groups, but the clinical 
significance is small. 
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Figure 30: Preoperative Duration of Symptoms vs Postoperative Buckley Scores in Group I 
(Dyspeptic) 
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 Table 13: Duration of Symptoms in Group I (Dyspeptic Group)  
 
 
  
 
Duration of Symptoms in the Dyspeptic Group
63 23.9 23.9 23.9
201 76.1 76.1 100.0
264 100.0 100.0
<=3 months
> 3 months
Total
Valid
Frequency Percent Valid Percent
Cumulative
Percent
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Table 14: Duration of Symptoms and Postoperative Buckley Score in Group I 
 
Months Postop Score <=6 Postop Score >6 
<=3  22 (34.9%) 41 (65.1%) 
>3  26 (13.1%) 173 (86.9%) 
p-value=0.087; Chi-square= 2.925 
 
Table 15: Duration of Symptoms and Postoperative Satisfaction in Group I 
 
Months Satisfied/Very Satisfied Not Satisfied 
<=3  60 (95.2%) 3 (4.8%) 
> 3  187 (94.0%) 12 (6.0%) 
p-value<0.001; Chi-square= 30.7 
removed two cases, no response 
 
5.11 Frequency of Episodes and Postoperative Buckley Score and Satisfaction after Surgery 
 The frequency of episodes prior to surgery relative to postoperative score and satisfaction 
from LC are shown in Tables 16 and 17. Eighty two patients (31.3%) had 3 or less episodes prior 
to LC, while 180 (68.7%) patients had more than 3 episodes prior to LC. Fifty eight patients 
(70.7%) who had 3 or less episodes prior to LC had postoperative Buckley scores greater than 6. 
One hundred and fifty six patients (86.7%) had more than 3 episodes prior to LC and had 
postoperative Buckley scores greater than 6. Of those having less than or equal to 3 episodes, 
95.2% were satisfied or very satisfied 1 year after LC. Of those having more than 3 episodes, 
only 94.0% were satisfied or very satisfied after LC. Table 16 and 17 show that there is a 
statistically significant difference, but the magnitude of the clinical significance is small. 
 Patient satisfaction in terms of both subjective response and Buckley scores are shown in 
Tables 18-20. In both groups, the majority of patients were very satisfied after LC and more than 
90% were either satisfied to very satisfied after surgery. However, only 49 patients (18.6%) in 
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Group I had postoperative Buckley scores less than 6 (complete cessation of symptoms), 
compared to the 215 patients (81.4%) of Group I who had postoperative Buckley scores larger 
than 6. 
 Table 16: Frequency of Episodes and Postoperative Buckley Score in Group I 
 
Episodes Postop Score <=6 Postop Score >6 
<=3   24 (29.3%) 58 (70.7%) 
>3  24 (13.3%) 156 (86.7%) 
p-value=0.01; Chi-square= 11.011 
 
Table 17: Frequency of Episodes and Postoperative Satisfaction in Group I 
  
Episodes Satisfied/Very Satisfied Not Satisfied 
<=3 78 (95.1%) 4 (4.9%) 
>3 170 (94.4%) 10 (5.6%) 
p-value<0.001; Chi-square= 51.011 
removed two cases, no response 
 Table 18: Postoperative Satisfaction in both Groups (I,II) -  Very Satisfied vs  
 Satisfied vs Not satisfied 
Group Very Satisfied Satisfied Not Satisfied 
Group I 162 (61.4%) 85 (32.2%) 15 (5.7%) 
Group II 62 (78.5%) 14 (17.7%) 3 (3.8%) 
p-value=0.149; Pearson Chi-Square= 6.771 
 
 
 Table 19: Postoperative Satisfaction in both Groups (I,II) – Satisfied/Very Satisfied  
  vs Not Satisfied 
 
 
 
 
p-value=0.023; Pearson Chi-Square= 5.185  
 
 
 
Group  Satisfied/Very Satisfied Not Satisfied 
Group I 247 (93.6%) 15 (5.7%) 
Group II 76 (96.2%) 3 (3.8%) 
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 Table 20: Postoperative Satisfaction in both Groups (I,II) in terms of Postoperative  
  Buckley Scores 
 
 
p-value = 0.71; Pearson Chi-Square= 0.142 
5.12 Gallbladder Pathology 
 The findings on microscopic examination of the gallbladder specimens for the two groups 
are shown in Table 21. Table 22 shows the results classified according to the presence or absence 
of chronic cholecystitis. The majority (62.4%) of Group I patients did not have chronic 
cholecystitis. Group I patients had histologic evidence of acute cholecystitis in 54.2% of cases. 
However, only a small number (N=21) had normal gallbladders (8.0%). This indicates that 91.6% 
of patients had cholecystitis (either acute or chronic). Group II patients had histologic evidence of 
chronic cholecystitis in 22.8% of specimens. Acute cholecystitis was identified in 64.6% of 
Group II specimens, and 12.7% of Group II specimens were normal. This was statistically 
significant, but clinically small. Table 23 shows the results classified according to the absence or 
presence of acute cholecystitis for the two groups. There was no significant difference between 
the two groups. The most important aspect of this table is the prevalence of acute cholecystitis 
among Group I which is quite similar to Group II.  
 Table 21: Pathology of Gallbladder Specimens 
  
Group Acute Chole Chronic Chole Normal 
*Group I 143 (54.2%) 99 (37.5%) 21 (8.0%) 
Group II 51 (64.6%) 18 (22.8%) 10 (12.7%) 
p= 0.448, Chi-Square= 3.7 
 
 
Group Postop Score<=6 Postop Score>6 
Group I 49 (18.6%) 215 (81.4%) 
Group II 44 (55.7%) 35 (44.3%) 
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Table 22: Pathology of Gallbladder Specimens relative to Chronic Cholecystitis 
 
Group Chronic Chole No Chronic Chole 
*Group I 99 (37.6%) 164 (62.4%) 
Group II 18 (22.8%) 61 (77.2%) 
p=0.003, Chi-Square=8.6 
*One specimen from the dyspeptic group was not retrievable 
 
 Table 23: Pathology of Gallbladder Specimens relative to Acute Cholecystitis 
  
Group Acute Chole No Acute Chole 
*Group I 143 (54.4%) 120 (45.6%) 
Group II 51 (64.6%) 28 (35.4%) 
 p-value=0.728; Chi-square= 2.042  
 *One specimen from the dyspeptic group was not retrievable 
 
5.13 Correlation of Gallbladder Pathology with Preoperative Ultrasound Findings 
 One hundred and forty three patients in Group I (54.2%) had histopathological evidence 
of acute cholecystitis. However, preoperative ultrasound diagnosed acute cholecystitis in only 33 
of Group I patients (23.1%). Ninety nine patients with microscopic chronic cholecystitis had 
preoperative ultrasound exams that showed acute cholecystitis in 14 patients (14.1%). Twenty 
one patients had normal gallbladders on histopathological examination. Of these specimens, 
preoperative ultrasound showed acute cholecystitis in 2 (9.5%).   
5.14 Analysis of patients with Postoperative Buckley scores of 7 to 15  
 Table 6a shows that 45.1% of group I patients (N=119) had postoperative scores between 
7 and 15. This group represents patients who had symptoms of dyspepsia prior to surgery but 
after surgery they do not have symptoms of dyspepsia and not asymptomatic as defined by the 
Buckley score. Table 24 and 25 show the preoperative and postoperative Buckley scores for each 
group. In Group II, there was a significant statistical difference with respect to epigastric pain 
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only.  In Group I, there was a statistical significant difference in all of the items of the Buckley 
score.  Table 26 shows the change in total Buckley score (severity+frequency+duration) for each 
item. Group I had a statistically significant difference in terms of epigastric pain reduction. There 
was a statistically significant difference in terms of reduction in heartburn and belching/bloating, 
but the clinical magnitude of this difference is quite small. 
Table 24: Analysis of Postoperative Buckley Score Patients (7-15): Group I: Dyspeptic          
Item    Preop  Postop  *p-value 
 
Epigastric pain 
 Severity  4 (5)   1 (1)   a  
 Frequency  1 (1)   0 (0)  a 
 Duration  3 (3)   0 (0)  a 
 
Heartburn 
 Severity  3 (3)  2 (2)  a  
 Frequency  1 (1)   1 (1)   a  
 Duration  2 (3)   1 (0)   a 
 
Belching/Burping 
 Severity  2 (2)   2 (1)   a 
 Frequency  1 (0)   1 (0)  a 
 Duration  1 (1)   1 (0)  a 
 
Bloating 
 Severity  2 (1)   1 (1)  a 
 Frequency  1 (0)   0 (0)  a 
 Duration  2 (0)  0 (0)  a 
*Wilcoxon Rank Sum test, a= <0.001 
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Table 25: Analysis of Postoperative Buckley Score Patients (7-15): Group II Non Dyspeptic       
 
Item    Preop  Postop  *p-value 
 
Epigastric pain 
 Severity  3 (5)  2 (1)  0.001     
 Frequency  1 (1)  1 (0)  0.07 
 Duration  2 (3)  1 (0)  0.022 
 
Heartburn 
 Severity  1 (1)  1 (1)  0.813 
 Frequency  0 (0)   0 (0)    0.527 
 Duration  0 (0)   0 (0)    0.340 
 
Belching/Burping 
 Severity  1 (1)    1 (1)    0.739 
 Frequency  0 (0)   0 (0)  0.317 
 Duration  0 (0)   1 (0)  0.035   
 
Bloating 
 Severity  1 (1)  1 (0)  0.035 
 Frequency  0 (0)   0 (0)  0.811   
 Duration  0 (0)  0 (0)  0.257 
*Wilcoxon Rank Sum test 
 
 
Table 26.  Of the patients with Postoperative Buckley scores of 7 to 15: the change in 
symptoms (Group I vs II) 
 
Item    Group I  Group II *p-value 
Epigastric Pain  7 (8)   2 (0)  <0.001 
Heartburn   3 (0)   0 (0)  0.032 
Belching/Bloating  1 (0)   0 (0)  <0.001 
Burping   0 (0)   0 (0)  0.08 
*Wilcoxon Rank Sum test  
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CHAPTER SIX 
 
DISCUSSION 
 
6.1 Correlation of Findings with Objectives and Corresponding Hypotheses 
Objective #1. To determine if laparoscopic cholecystectomy in patients with gallstones 
and symptoms of dyspepsia will achieve complete symptomatic relief. Complete symptomatic 
relief will be defined as the cessation of symptoms of dyspepsia after laparoscopic 
cholecystectomy.  
Hypothesis #1: Laparoscopic cholecystectomy for patients with gallstones and symptoms 
of dyspepsia will achieve complete symptomatic relief 1 year post laparoscopic cholecystectomy 
in 70% of patients. 
 We expected 70% of Group I patients to have postoperative Buckley scores less than 6 
one year after LC. We found this not to be the case (Table 5, 6a). We found that 80% of this 
group had Buckley scores greater than 6 (table 5, 6a). However, this same group who all had 
preoperative Buckley scores greater than 16, 179 (67.8%) patients had Buckley scores of 16 or 
less after surgery, indicating a dramatic improvement after surgery.  Our results are very similar 
to the 70% improvement rate quoted in the literature (7-9). The patients’ satisfaction with the 
results of surgery was found to be either satisfied or very satisfied in over 90% (table 6b). This 
subjective index does not correlate with the postoperative Buckley scores. This is expected as this 
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suggests that the pathophysiology for dyspepsia is not solely linked to gallstones. Proposed 
mechanisms for dyspepsia are visceral hypersensitivity and possibly altered gastric motility (32).  
Therefore, LC would have a minimal effect on these symptoms. 
 Objective #2: To compare the change in the preoperative score to the postoperative score 
and satisfaction after laparoscopic cholecystectomy for the two groups: patients with gallstones 
and symptoms of dyspepsia and the patients with gallstones and no symptoms of dyspepsia.  
Hypothesis #2: Patients with gallstones and no symptoms of dyspepsia would have a 
greater reduction in the Buckley score and greater satisfaction after laparoscopic cholecystectomy 
compared to those patients who have gallstones and symptoms of dyspepsia. 
 Our findings were not consistent with our hypothesis (table 9) because the following 
symptoms showed a larger change in Buckley scores from preoperative to postoperative for each 
component in Group I: epigastric pain (severity, duration), heartburn (severity, frequency, 
heartburn), belching/burping (frequency) and bloating (severity, frequency, duration). This would 
be expected as the Buckley score is biased in favor of the non dyspeptic group, who by 
definition, have scores that are less to begin with. This bias may result in a larger change from 
preoperative to postoperative scores for the dyspeptic group. We then looked at patient 
satisfaction after surgery and its lack of correlation with the changes in the Buckley score (tables 
18-20). Patient satisfaction, although subjective in nature, correlated more with microscopic 
examination of the gallbladder specimens. 
Most patients in Group I had evidence of acute cholecystitis (>50%) which was very 
surprising, and thus reflects the satisfaction experienced by these patients from having the 
surgery to have the recurring or acutely inflamed gallbladder removed. When the symptoms of 
the Buckley score were summed up individually and compared (tables 10-12), there were 
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statistically significant differences in all items with respect to Group I. As the clinical magnitude 
of this difference was large for the epigastric pain symptoms and small for the others symptoms. 
This differs from standard surgical dogma.  
Objective #3: To determine the relationship between the duration of preoperative episodes 
and the probability of complete resolution of symptoms following laparoscopic cholecystectomy 
in patients with gallstones and symptoms of dyspepsia. Duration measured by the total period of 
time between onset of symptoms and laparoscopic cholecystectomy.  
Hypothesis #3: Early laparoscopic cholecystectomy for patients with gallstones and 
symptoms of dyspepsia will achieve complete symptomatic relief 1 year post laparoscopic 
cholecystectomy in 70% of patients. Early laparoscopic cholecystectomy is defined by surgical 
intervention at or before three months of symptoms. 
 Our findings for duration of symptoms and postoperative score were not consistent with 
our expectations (figure 30 and tables 13,14). We expected patients with less than 3 months of 
symptoms to have complete cessation of symptoms, a postoperative Buckley score of less than 6 
after one year. We found that most patients with symptoms for less than 3 months had 
postoperative Buckley scores greater than 6 (Table 13). However, most of these patients were 
satisfied or very satisfied with the LC, which again does not correlate well with the postoperative 
score because of the level of subjectivity. Our findings are similar to the findings of Luman et al 
(15) who found that most of the patients who had persistent symptoms after surgery had 
symptoms less than 6 months of duration. Our patient group was larger (N=264) compared to the 
study done by Luman (N=10). Our findings are consistent with Lublin et al (16) who also found 
that longer duration of pain experienced preoperatively was predictive of persistent pain after 
surgery. 
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 Objective #4: To determine the relationship between the frequency of preoperative 
episodes and the probability of complete resolution of symptoms following laparoscopic 
cholecystectomy in patients with gallstones and symptoms of dyspepsia. Frequency measured by 
the number of episodes in the period of time prior to laparoscopic cholecystectomy.  
      Hypothesis #4: Patients with gallstones and symptoms of dyspepsia will experience 
complete resolution of symptoms when laparoscopic cholecystectomy is performed prior to or at 
the third episode. 
 Similarly we found that the frequency of attacks prior to surgery and postoperative score 
were not as predicted. More than 70% of patients in Group I with less than 3 attacks prior to 
surgery had postoperative scores greater than 6 (Table 16). However, the subjective description 
of satisfaction from surgery does not correlate with the postoperative scores (Table 17). Our 
finding is similar to the finding of Lublin et al. (16) who identified patients having frequent 
episodes of pain preoperatively was predictive of persistent pain after surgery. 
 Our results indicate that patients with symptoms of dyspepsia were content with the 
surgery because of a reduction in symptoms rather than complete resolution of symptoms. This 
may be in terms of symptoms reduction which could be decrease in terms of duration, frequency 
and severity. This may reflect an understanding of the expectations of the patients prior to 
surgery. The discussion with the surgeon prior to surgery may have included no guarantee that 
the procedure would cure them of dyspepsia and may only produce a reduction in symptoms. 
This reduction in symptoms is what our results support. The lack of correlation between the 
Buckley postoperative score and the patients’ subjective satisfaction with LC is obvious. From 
the patients’ viewpoint, satisfaction from LC is important and may be more important than the 
score.  
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 Objective #5: To determine the differences in pathologic findings between patients with 
gallstones and no symptoms of dyspepsia versus patients with gallstones and symptoms of 
dyspepsia.  
 Hypothesis #5a: Patients with no symptoms of dyspepsia and ultrasonagraphic evidence 
of gallstones would be found to have no morphological evidence of chronic cholecystitis. 
 Hypothesis #5b: Patients with symptoms of dyspepsia and ultrasonagraphic evidence of 
gallstones would be found to have morphological evidence of chronic cholecystitis. 
 The microscopic examination of the pathological specimens reveals that the majority of 
patients in Group I did not have evidence of chronic cholecystitis. In addition, the majority of 
Group II patients did not have evidence of chronic cholecystitis. However, it is clear that the 
majority of patients in Group I (54.2%) had evidence of acute cholecystitis (Tables 21, 23). This 
confirms our previous findings and supports that these patients had histopathologic evidence of 
disease and removal may have improved there symptoms thereby justifying there subjective 
responses to satisfaction from LC. As previously mentioned, Luman et al (15) found that in 
patients, who had persistent symptoms after surgery (N=13), 77% had no or mild histological 
changes of cholecystitis. Our results are more pronounced and are significantly different from 
Luman et al (15). Our study supports the histopathologic presence of acute cholecystitis in 
patients with symptoms of dyspepsia and supports LC in this group of patients to achieve a 
symptomatic reduction that is quite satisfying to the patient.  
 In Group I patients, there were 119 patients (45.1%) that had postoperative Buckley 
scores between 7 and 15 (table 6a). This represents a very unique group. All the patients in this 
group had Buckley scores above 16 before surgery and were defined as dyspeptic After surgery 
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this group that did not achieve complete symptomatic relief (score <6) and but were not defined 
to be persisting dyspeptic patients. Tables 24-26 demonstrate that the patients like Group I, 
benefit from surgery in terms of clinical reduction in epigastric pain as well as a minor reduction 
in the remainder of the items (p-value<0.001).  
 The duration of time between onset of symptoms and surgery was on average 36 months 
for Group I. Intuitively this seems reasonable for these patients did not exhibit both clinical and 
radiological evidence of acute biliary pathology and therefore were not offered LC early 
(emergently).  
 Gerd et al (33) identified diarrhea after laparoscopic cholecystectomy in 12-33% of 
patients. Our results indicate an overall incidence of diarrhea in both groups of patients to be 
41.1% (Table 2), which is higher than other studies (33, 16). Lublin et al (16) found in a 21% 
incidence of diarrhea after surgery. Our results indicate that the incidence of diarrhea in patients 
with gallstones and symptoms of dyspepsia (Group I) was 45.5% (Table 3). The accepted 
mechanism for post cholecystectomy diarrhea seems to be bile salt malabsorption which is 
relieved by treatment with cholestyramine (33). Group I patients (45.5%) had an incidence of 
diarrhea after surgery was nearly doubled compared to Group II patients (26.6%). We suggest 
that post laparoscopic cholecystectomy bile salt malabsorption may exacerbate the dyspeptic 
patients’ preoperative bowel abnormalities. 
 In summary, patients with gallstones and symptoms of dyspepsia will benefit from LC in 
terms of symptomatic reduction especially the epigastric pain component and are very 
satisfied/satisfied after LC.   
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6.2 Study Strengths  
 This is the first North American study to investigate the study questions of interest and 
the largest number of patients to date that was conducted 14 years after LC became the gold 
standard. This study has the largest sample size and more of a balanced proportion of men to 
female. This is the first study that used a validated scoring system to properly identify patients 
with dyspepsia.  
 The methodology was a retrospective cohort and was the most appropriate choice for the 
given time period of study. We were fortunate to have the data collection and survey return 
analysis completed in 8 months. This same study if prospectively conducted would have required 
a minimum of four years to complete. 
6.3 Study limitations 
 Patient recruitment initially was over a one year period. It was not possible to recruit the 
desired number of patients in this time period. The number of nonresponders and noncontacts 
were much higher than anticipated. This may have been a consequence of the nature of our chart 
review. The mailing addresses were derived from the chart review and may not have been the 
most current address. We altered the dates to include more patients, acknowledging the potential 
disadvantage of longer interval between operation and survey response, thus a potential for 
memory recall bias.  
 We recognize that the two groups: Group I and II may not be mutually exclusive in terms 
of symptoms. The Buckley score allowed us to stratify patients into two distinct artificial groups 
for the purpose of the study. In clinical practice this may not be as easily done. We depended on 
the Buckley score as this was the only validated tool available to identify patients with dyspepsia. 
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The Buckley score is not without its imperfections. Future work need to be done to improve the 
tool and improve its clinical utility. 
 Our study sample consisted of patients with and without symptoms of dyspepsia. The 
sample size is larger than the calculated sample size as per the power analysis. This was 
attributed to the length of time required to accrue the patients. There was a potential risk of 
making a type II error. However, in our study, we were able to observe statistical significance on 
the observed outcomes therefore power of the study is not an issue. 
 In our study we used statistical tests repeatedly and multiple comparisons. There is a 
potential increase in Type I error that occurs as a consequence when statistical tests are used 
repeatedly. However, the level of significance is so great (p-value<0.001) on the key findings that 
the difference being due to chance is unlikely.  
 The number of nonresponders and noncontacts was quite high (443 and 141 respectively). 
Nonresponders are those that a questionnaire package was sent to and was not returned. This 
implies, either the respondent received the questionnaire and did not respond, or did respond and 
did not return or the respondent may not have even been at the address to receive the package 
(away for the period of study). The noncontacts are those that a questionnaire package was sent 
and the postal carrier returned to the author due two main factors: person has moved or not the 
correct address. Collectively, this number is more than the actual number of study participants 
(343), and has the potential to considerably bias our results and conclusions.  We were fortunate 
to abstract data from the chart review in relation to this group of participants and compare these 
characteristics to our study population in Table 1. We found that the two groups were similar in 
more than 90% of the items and only differed statistically in the age item. The study participants 
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(mean age=51 years) was slightly higher than the nonresponder and noncontact group (age=46 
years).  This table was good for the basic features but not for outcomes. 
 The questionnaire’s content and nomenclature may have posed a difficulty in 
understanding and patients may have responded inappropriately. The glossary was provided to 
detail the descriptions of procedures (CT scan, gastroscopy, ERCP etc) to help alleviate this. It is 
important to note, that during procedures such as gastroscopy and ERCP, most physicians use 
some type of sedation that mostly impairs patients from recalling the experience. Again, the 
majority of our patients are middle aged and fairly devoid of systemic ailments (Alzheimer’s, 
dementia, stroke etc.). At the same time, the questionnaire was sent during the periods of June 
and August, this is the time where most people are on holidays and could have affected response 
rate.  
 The questionnaire was self administered. It contained sections pertaining to before and 
after surgery. It is possible that patients may have ignored the “after surgery” and answered the 
same questions as per prior surgery. This could have a significant impact on our results. 
Conducting this study prospectively would minimize this.  
 Memory recall may have been a concern. We felt that gallbladder attacks are quite painful 
and most people do not forget such pain. The mean age was 50 and this patient group is middle 
aged and with minimal to no co morbidities and probably have little concern for memory recall. 
Also, because our time interval was longer than 1 year post surgery, this may have had an impact 
on the patient’s ability to recall. However, during the data collection and survey collection period, 
there was no patient that had written on the returned survey, that they could not recall there 
symptoms accordingly.  
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6.4 Future Research  
 The same study can be conducted prospectively over 5 year period using the same survey 
protocol to investigate the same research questions. This would lower the memory recall bias 
completely and allow us to follow patients over the one year time interval. Prior to LC and at the 
time of consent for LC, the questionnaire would be distributed. One year follow up with the 
patients after LC would be easily done with a more valid and current mailing addresses. In 
addition, the use of a quality of life index to determine qualitatively how patients are 
postoperatively. 
 The long term sequelae of LC in patients with uncomplicated gallstone disease and 
symptoms of dyspepsia would be important to investigate. Long term follow up is unavailable in 
this particular group and it would be interesting to see how these patients do after 10 or 20 years 
after surgery. 
 The postoperative diarrhea experienced by patients was much higher in Group I than 
Group II. We were unable to characterize the extent of this complication for this was not the 
focus of our study. We identified this as a key finding as this does exceed the quoted literature 
value. Future research is needed to identify the character (watery vs. loose), frequency, severity, 
duration, affect on quality of life and treatment of this complication. 
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CHAPTER SEVEN 
CONCLUSIONS 
 
 LC in patients with gallstones and symptoms of dyspepsia does not achieve complete 
symptomatic (81.4%) relief 1 year after surgery. Group I had a greater reduction in the Buckley 
score than Group II after LC but had similar rates of satisfaction from surgery. The duration of 
preoperative episodes of gallbladder had no relation to the outcome of surgery. The frequency of 
preoperative episodes of gallbladder had no relation to the outcome of surgery. The majority of 
patients in both Group I (54.2%) and Group II (64.6%) were found to have acute cholecystitis 
and only a minority had morphological evidence of chronic cholecystitis. Patients with gallstones 
and symptoms of dyspepsia will benefit from LC in terms of symptom reduction especially the 
epigastric pain symptom and a great proportion are satisfied or very satisfied after LC.   
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APPENDIX A: Questionnaire 
 
Patient identification number: 
 
Part I: BEFORE SURGERY 
 
–PLEASE ANSWER THE FOLLOWING AS YOU HAD EXPERIENCED 
BEFORE YOUR GALLBLLADDER WAS REMOVED 
  
1. How long did you have your symptoms/pain/discomfort before your 
laparoscopic cholecystectomy? Please indicate number of: 
  
____  Days 
 
____  Weeks 
 
____  Months 
 
____  Years 
 
 
2. How many gallbladder attacks (abdominal pain) did you have prior to your 
laparoscopic cholecystectomy? 
 
□ 1 
□ 2 
□ 3 
□ 4 
□ 5  
  
 if greater than five attacks, how many? 
 
3. Did you have a gastroscopy (stomach scope) before your laparoscopic 
cholecystectomy?  
 
□ Yes  
□ No  
  
If Yes,  
a) Was it normal or abnormal? 
  
□ Normal 
□ Abnormal 
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b) When was it in relation to your operation (weeks before surgery)?  
 
□ 1 week 
□ 4 weeks 
□ 8 weeks 
□ 12 weeks 
□ 24 weeks 
□ 48 weeks       
 
4. Have you ever taken over the counter medicines for indigestion or pain in 
the year prior to your laparoscopic cholecystectomy?     
 
□ Yes   
□ No 
 
5. What prescribed medicines for indigestion were you taking prior to your 
laparoscopic cholecystectomy? 
 
 
 
6. Were you ever hospitalized with a fever during your gallbladder attack? 
  
□ Yes  
□ No 
 
 
7. What other illnesses/conditions do you have, please circle any of the 
following that applies to you? 
 
□ Diabetes Mellitus 
□ Heart disease 
□ Stroke 
 
8. Please complete the following section by for each of your symptoms as 
described below: 
 
for Severity please refer to the following as a guide to your answer:  
 none 
 mild = Can be ignored when you do not think about it 
 moderate = Cannot be ignored 
 severe = Influences concentration on daily activities 
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 very severe = Markedly affects daily activities and/or requires rest 
 
1. Epigastric Pain (pain or discomfort localized in the upper abdomen) 
 
a)Severity: 
 
□ none, go to question #2 Heartburn 
□ mild 
□ moderate 
□ severe 
□ very severe 
 
b) Frequency of attacks 
 
□ less than 3/week 
□ more than 3/week 
□ more than 1/day 
□ continuous 
 
c) Duration of attacks 
 
□ less than 10minutes 
□ 10 to 30 minutes 
□ more than 30 minutes 
  
2. Heartburn (burning sensation, usually centered in the middle of the chest, 
near breastbone) 
 
a)Severity 
 
□ none, go to question #3 Belching/Burping 
□ mild 
□ moderate 
□ severe 
□ very severe 
 
b) Frequency of attacks 
 
□ less than 3/week 
□ more than 3/week 
□ more than 1/day 
□ continuous 
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c) Duration of attacks 
 
□ less than 10minutes 
□ 10 to 30 minutes 
□ more than 30 minutes 
 
3. Belching/Burping (expel gas noisily from the stomach through the mouth) 
a)Severity 
  
□ none, go to question #4 Bloating 
□ mild 
□ moderate 
□ severe 
□ very severe 
 
b) Frequency of attacks 
 
□ less than 3/week 
□ more than 3/week 
□ more than 1/day 
□ continuous 
 
c) Duration of attacks 
 
□ less than 10minutes 
□ 10 to 30 minutes 
□ more than 30 minutes 
 
4. Bloating** (swell up or distended abdomen with liquid or gas) 
a)Severity: 
 
□ none, go to PART II 
□ mild 
□ moderate 
□ severe 
□ very severe 
 
b) Frequency of attacks 
 
□ less than 3/week 
□ more than 3/week 
□ more than 1/day 
□ continuous 
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c) Duration of attacks 
 
□ less than 10minutes 
□ 10 to 30 minutes 
□ more than 30 minutes 
 
PART II: AFTER SURGERY 
 
-PLEASE ANSWER THE FOLLOWING AS YOU ARE AT PRESENT, 
SINCE YOUR GALLBLLADDER WAS REMOVED  
 
1. How long has it been since you had your laparoscopic cholecystectomy? 
 
□ 12 months 
□ 18 months 
□ 24 moths 
 
 
2. Are you satisfied with your laparoscopic cholecystectomy? 
 
□ Not Satisfied 
□ Satisfied 
□ Very Satisfied 
 
3. Since your laparoscopic cholecystectomy, have you seen your: 
 
 a) Family Physician because of pain similar to your gallbladder attacks?  
 
□ Yes    
□ No 
 
 b) Family Physician because of any problems with your digestion?  
 
□ Yes 
□ No  
 
 c) Surgeon related to pain or any other problems related to your gallbladder 
operation?  
 
□ Yes   
□ No 
  
 If yes, how many times? 
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4. Since your laparoscopic cholecystectomy, have you had any of the following 
tests: 
 a) Gastroscopy?  
 
□ Yes   
□ No 
 b) Endoscopic Retrograde CholangioPancreatography, ERCP?  
 
□ Yes  
□ No  
 e) Ultrasound (U/S) or Computer Tomography (CT) scan of abdomen?  
 
□ Yes  
□ No 
 
5. Since your laparoscopic cholecystectomy, have you had to see any other 
specialists concerning your symptoms/pain/discomfort?    
 
□ Yes 
□ No   
 If yes, type of specialist: 
 
6. Have you taken ulcer medicines since your laparoscopic cholecystectomy? 
 
□ Yes  
□ No 
  
      If yes, same, more or less?     
 
□ Same     
□ More        
□ Less 
  
7. Have you been experiencing diarrhea since your laparoscopic 
cholecystectomy?         
 
□ Yes 
□ No 
 
8. What prescribed medicines have you taken since your laparoscopic 
cholecystectomy? 
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9. Please complete the following section for each of your symptoms as described 
below: 
 
for Severity please refer to the following as a guide to your answer:  
 
 none 
 mild = Can be ignored when you do not think about it 
 moderate = Cannot be ignored 
 severe =  Influences concentration on daily activities 
 very severe = Markedly affects daily activities and/or requires rest 
 
1. Epigastric Pain (pain or discomfort localized in the upper abdomen) 
 
a)Severity: 
 
□ none, go to question #2 Heartburn 
□ mild 
□ moderate 
□ severe 
□ very severe 
 
b) Frequency of attacks 
 
□ less than 3/week 
□ more than 3/week 
□ more than 1/day 
□ continuous 
 
c) Duration of attacks 
 
□ less than 10minutes 
□ 10 to 30 minutes 
□ more than 30 minutes 
  
2. Heartburn (burning sensation, usually centered in the middle of the chest, 
near breastbone) 
 
a)Severity 
 
□ none, go to question #3 Belching/Burping 
□ mild 
□ moderate 
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□ severe 
□ very severe 
 
b) Frequency of attacks 
 
□ less than 3/week 
□ more than 3/week 
□ more than 1/day 
□ continuous 
 
c) Duration of attacks 
 
□ less than 10minutes 
□ 10 to 30 minutes 
□ more than 30 minutes 
 
3. Belching/Burping (expel gas noisily from the stomach through the mouth) 
a)Severity 
 
□ none, go to question #4 Bloating 
□ mild 
□ moderate 
□ severe 
□ very severe 
 
b) Frequency of attacks 
 
□ less than 3/week 
□ more than 3/week 
□ more than 1/day 
□ continuous 
 
c) Duration of attacks 
 
□ less than 10minutes 
□ 10 to 30 minutes 
□ more than 30 minutes 
 
4. Bloating** (swell up or distended abdomen with liquid or gas) 
a)Severity: 
 
□ none, go to question #5 
□ mild 
□ moderate 
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□ severe 
□ very severe 
 
b) Frequency of attacks 
 
□ less than 3/week 
□ more than 3/week 
□ more than 1/day 
□ continuous 
 
c) Duration of attacks 
 
□ less than 10minutes 
□ 10 to 30 minutes 
□ more than 30 minutes 
 
 
5. DO YOU OBJECT TO BEING CONTACTED FOR FURTHER 
INFORMATION, IF REQUIRED?  
□ YES  
□ NO 
 
 
 
THE END 
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APPENDIX B: PILOT STUDY 
 
PURPOSE 
    To determine the feasibility of the project. 
MATERIALS AND METHODS 
 A retrospective chart review of all laparoscopic cholecystectomies since 2003 performed 
by two General Surgeons at the Royal University Hospital.  
INCLUSION CRITERIA 
 All patients with laparoscopic cholecystectomy who had uncomplicated gallstone disease. 
Patients will be identified as those with uncomplicated gallstone disease defined as biliary colic 
and cholelithiasis.  
EXCLUSION CRITERIA 
The exclusion criteria involves patients with any one of the following: previous common bile 
duct stones (choledocholithiasis), obstructive jaundice, cholangitis, gallstone pancreatitis, 
cholecystoenteric fistula, gallbladder neoplasm, previous biliary/pancreatic surgery, open 
cholecystectomy, previous gastric surgery. Patients with signs and symptoms of systemic disease: 
fever, leukocytosis, inflammatory mass and jaundice will also be excluded. 
RESULTS (REFER TO GRAPHS) 
Forty three patients of 119 (36%) patients fit the inclusion criteria.  Average age was 46.2 
yrs (range 15-88 yrs). Timing of laparoscopic cholecystectomy from onset of symptoms was an 
average of 13.6 months (range 0.02-72 months. Fifteen (34%) patients were male and 28 (65%) 
patients were female. Patients who had gallbladder related symptoms were as follows: abdominal 
pain (14), biliary colic (9), mixed symptoms (17), and 1 was asymptomatic. Patients with 
dyspepsia were 28. No patients had pain radiating to the shoulder tip. Other dyspeptic symptoms 
were found as: nausea (21), vomit (18), anorexia (2), fatty food intolerance (2), heartburn (1), and 
flatulence (2). No patients complained about belching or borborygmi. Psychiatric determinants 
were found as:  depression (2), anxiety (2), and use of psychotropic medications (1). None were 
introverted or extroverted. Ultrasonagraphy of the abdomen showed that 37 patients had 
gallstones, 2 had no stones, and 5 had mixed findings. Pathological findings were as follow: 27 
had cholecystitis and stones, 5 had cholecystitis, stones and cholesterolosis, 4 had stones, 1 had a 
polyp, and 8 had mixed findings. Preoperative to postoperative diagnosis ratio were found to be: 
cholelithiasis 18/16, biliary colic 17/18, acute cholecystitis 5/6, biliary dyskinesia 1/1, and other 
2/2. Eighteen patients were diagnosed with biliary colic based on intraoperative findings. Of 
these 18 patients, 16 (89%) had pathological features consistent with chronic cholecystitis. 
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CONCLUSIONS 
 
From our pilot study, which selected patients by laparoscopic cholecystectomy, identified 
patients with symptoms of dyspepsia were included in this group. Secondly, we identified that 
preoperative clinical findings, ultrasound report and intraoperative observations did not correlate 
with the pathological diagnosis. The proposed study is feasible. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Preoperative versus Postoperative (Intraoperative) Diagnosis
0
2
4
6
8
10
12
14
16
18
20
cholelithiasis biliary colic acute
cholecystitis
biliary
dyskinesia
other
Diagnosis
N
um
be
r,
 N
Preoperative Diagnosis
Postoperative Diagnosis
 101
Appendix C: Research Participant Information and Consent Form 
 
Project title: Laparoscopic cholecystectomy and the dyspeptic patient: Developing a tool to 
stratify the appropriateness of operative intervention.  
 
Principal Investigators: Drs. Roger Keith and B. Reeder, Dept. of Surgery. 
 
Sub-Investigator: Dr. Samaad Malik, Dept. of Surgery.  
 
 You have been invited by your surgeon, because you recently had surgery to remove your 
gallbladder, to participate in a research project being conducted in the Department of Surgery at 
the University of Saskatchewan. Your participation is entirely voluntary. It is up to you to decide 
whether or not to take part in this study. Before you decide, it is important for you to understand 
what the research involves. This consent form will tell you about the study, why the research is 
being done and the possible benefits, risks and discomforts.  
 If you wish to participate, you will be asked to sign this form. If you decide to take part in 
this study, you are still free to withdraw at any time and without giving any reasons for your 
decision. If you do not wish to participate, you do not have to provide any reason for your 
decision. You will not lose the benefit of any medical care to which you are entitled or are 
presently receiving.  
 Please read this form carefully and feel free to discuss it with your family, friends and 
doctor before you decide.  
 
Purpose of the study: 
 At present, we do not know the best time to remove the gallbladder from patients with 
gallstone disease. Patients with gallstones have various symptoms. We hope this study will help 
to identify the best time for gallbladder removal in order to obtain long term patient satisfaction 
following the operation.  
 
Procedures: 
 We are asking your permission to review your medical chart to identify the various 
laboratory tests that were done and to look at the gallbladder pathology report. The chart review 
will not be used to identify any other features of personal or other health related information. We 
are also asking you to complete a survey questionnaire about your symptoms and other relevant 
information before and after your operation. The survey takes approximately 5 minutes to 
complete. You do not have to answer any questions you are not comfortable answering.  
 Dr. Samaad Malik, who is a surgical resident in the Department of Surgery at the 
University of Saskatchewan, will conduct the data analysis. Both the signed consent form and the 
survey questionnaire should be returned to Dr. Samaad Malik in the self-addressed envelope. 
 
Benefits: 
 There will be no direct benefits to you for participating in this study. We hope that the 
information gained from this study can be used in the future to benefit other people with a similar 
condition. 
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Risks and discomforts: 
 There are no physical risks associated with this study.  
 
Confidentiality: 
 The researchers will protect your privacy and safeguard the confidentiality of information 
collected about you in this study. While absolute confidentiality cannot be guaranteed, every 
effort will be made to ensure that the information you provide is kept entirely confidential. Your 
name will not be attached to any information, nor mentioned in any report, nor made available to 
anyone outside the research team. It is the intention of the research team to publish results of this 
study in scientific journals and to present the findings at related conferences and workshops, but 
your identity will not be revealed.  
  
Voluntary participation / withdrawal 
Your participation in this research is entirely voluntary. If you choose to enter the study 
and then decide to withdraw at a later time, there will be no penalty or loss of benefits to which 
you are entitled, and your future medical care will not be affected. The data collected about you 
during your enrolment will be retained for analysis. 
 
Costs and reimbursements: 
 There is no cost to you for participating in this study. You will not be paid for your 
participation.  
 
Who to contact for questions about this study: 
 If you have any questions about this study, you can contact The Principal Investigators, 
Dr. R. Keith (966-8631) or Dr. B. Reeder (966-7930) or Dr. Samaad Malik, who is in charge of 
the data analysis at 966-8631. 
 If you have any questions about your rights as a research subject or concerns about the 
study, you should contact the Chair of the Biomedical Research Ethics Board, c/o Ethics Office, 
University of Saskatchewan at (306) 966 4053. Collect calls are accepted.  
 
Consent: 
 
I, _____________________________________________________, have read and 
understand the above information and agree to participate in the study entitled: Laparoscopic 
Cholecystectomy and the Dyspeptic Patient: Developing a tool to stratify the 
appropriateness of operative intervention. I understand that my participation is voluntary and 
that all the information collected will be kept confidential and used only for scientific objectives. 
I am not waiving any of my legal rights by signing this consent form.  I freely consent to 
participate in this study.    
Signature___________________________________________ Date______________ 
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APPENDIX D: Surgeon’s Letter Head 
 
Dear Person’s Name 
 
You are one of my patients who had their gallbladder removed by the Laparoscopic Technique. I 
am inviting you to participate in a research study, which is described in more details in the 
accompanying “Research Participant Information and Consent Form”. The purpose of this study 
is to evaluate what is the best time for this operation in patients who have gallbladder pain and/or 
digestive symptoms. 
 
Your participation is entirely voluntary. If you do not wish to participate, you do not have to 
provide any reason for your decision. It will not affect your relationship with me and you will not 
lose the benefit of any medical care to which you are entitled or are presently receiving. 
 
There are two aspects to the study. A medical chart review is required to identify laboratory tests 
and gallbladder pathology. The chart review will not be used to identify any other features of 
personal or other health related information. The second aspect of the study is a survey 
questionnaire which is enclosed. The survey consists of questions about your symptoms and 
relevant information before and after your operation. It will take approximately 5 minutes to 
complete. All the information collected for the study will remain completely confidential, and 
you will not be identified by name in any aspect of the research study. The data and all 
corresponding information collected will be destroyed after research analysis. 
 
If you agree to take part in this study, your medical chart review will be done by a surgical 
research associate in the Department of Surgery, Dr. Samaad Malik. Dr. Malik is conducting this 
study as a requirement for a Masters of Science Degree from the University of Saskatchewan. 
 
A consent form is also enclosed. Your signature is required to indicate your agreement to 
participate in this study. Please return the signed consent form and the completed survey in the 
self-addressed, stamped envelope which is enclosed.  
 
I appreciate your contribution to ongoing surgical research in Saskatchewan. 
 
 
Yours sincerely, 
 
 
 
 
 
Dr. Surgeon 
Appendix E: Ethics 
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APPENDIX F: CHART REVIEW DATA COLLECTION SHEET 
Surgeon Surgeon Surgeon Surgeon
MRN MRN MRN MRN
Mr/Mrs/ Dr/Miss Mr/Mrs/ Dr/Miss Mr/Mrs/ Dr/Miss Mr/Mrs/ Dr/Miss
Last Name: Last Name: Last Name: Last Name:
First Name: First Name: First Name: First Name:
Age Age Age Age
Date of birth Date of birth Date of birth Date of birth
Address Address Address Address
Postal code Postal code Postal code Postal code
City City City City
Province Province Province Province
Gender 1- Male Gender 1- Gender 1- Gender 1-
2- Female 2- 2- 2-
Investigations Investigations Investigations Investigations
1- gallstones 1 1- 1-
2- acute chole 2- 2- 2-
3- no stones 3-    3- 3-
4- other 4-     4- 4-
Emergent vs elective 1 or 2 1 or 2 1 or 2
Date of OR Date of OR Date of OR Date of OR
Preop diagn Preop diagn Preop diagn Preop diagn
1- Cholelithiasis 1-     1- 1-
2- bc 2-     2- 2-
3- acute chol 3-     3- 3-
4- biliary dysk 4-   4- 4-
5- other 5-    5- 5-
Postop diagn Postop diagn Postope diagn Postope diagn
1-    
1- Cholelithiasis 2-    1- 1-
2- bc 3-    2- 2-
3- acute chol 4-   3- 3-
4- biliary dysk 5-    4- 4-
5- other 5- 5-
SAN
SAN SAN SAN
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